Browsing Tag
SCENESSE
3 posts
Clinuvel Pharmaceuticals (ASX: CUV; Nasdaq: CUVL) reorganises around U.S. markets after Nasdaq debut
Clinuvel Pharmaceuticals is aligning its organisation with an increasingly U.S.-centred commercial and clinical strategy, but the value of the reset will depend on measurable progress rather than greater Nasdaq visibility alone.
Clinuvel Pharmaceuticals (ASX: CUV) share price gains after EMA approves year-round SCENESSE dosing
Clinuvel Pharmaceuticals (ASX: CUV) gains EMA approval for year-round SCENESSE dosing, boosting patient access, revenues, and investor sentiment.
Can SCENESSE become the first approved EPP treatment in Canada? Clinuvel files with Health Canada
Clinuvel Pharmaceuticals files for SCENESSE approval in Canada, aiming to bring the first-ever EPP treatment to patients. Find out how it could change lives.